Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study

Fig. 4

Multivariate analysis of factors associated with markers of atherogenic dyslipidemia. (a) Low HDL-C levels; (b) high TG levels; (c) low HDL-C and high TG levels. p < 0.0001 for all factors. Countries of origin with an OR that was not significant have been omitted. aPer year. bRelative to male participants. cRelative to not having T2DM. dBMI ≥ 30 kg/m2, relative to not being obese. ePer mmol/l. fPer mg/l. gRelative to never smoking. hRelative to non-use. iRelative to the UK. Abbreviations: BMI body mass index, CI confidence interval, CRP C-reactive protein, HDL-C high-density lipoprotein cholesterol, OR odds ratio, T2DM type 2 diabetes mellitus, TG triglyceride

Back to article page